You are here


CDC Reports Pneumonia, Influenza Mortality Rate Hits Epidemic Threshold

CLICK HERE - CDC - FLUVIEW - Weekly U.S. Influenza Surveillance Report

CLICK HERE - CDC - Weekly US Map: Influenza Summary Update

CLICK HERE - CDC - Situation Update: Summary of Weekly FluView Report

CLICK HERE - CDC - Past Weekly Surveillance Reports - February 10, 2017

The mortality rate for pneumonia and influenza in the United States was slightly above the epidemic threshold during the week ending Jan. 7, according to CDC’s FluView.



Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

The Mission to Stop Ebola: Lessons for UN Crisis Response

CLICK HERE - International Peace Institute - The Mission to Stop Ebola: Lessons for UN Crisis Response (28 page .PDF report) - February 15, 2017

Executive Summary

The Ebola epidemic of 2014–2016 was a fastmoving, multidimensional emergency that pre - sented unprecedented challenges for the multi - lateral system. In response to the outbreak, which was spreading exponentially in Guinea, Liberia, and Sierra Leone, Secretary-General Ban Ki-moon established the UN’s first-ever emergency health mission, the UN Mission for Ebola Emergency Response (UNMEER). UNMEER was mandated by the UN General Assembly in September 2014 to scale up and coordinate the activities of the UN presence on the ground working to stop the outbreak, which eventually claimed over 11,000 lives.

This report asks: Was UNMEER needed? Was it properly structured? Did it deliver? And what broader lessons can be learned from the experience of UNMEER for UN crisis response?

Problem, Solution, SitRep, or ?: 

Ebola 'Super-Spreaders' Cause Most Cases


Getty Images

CLICK HERE - PNAS - Spatial and temporal dynamics of superspreading events in the 2014–2015 West Africa Ebola epidemic - by James Gallagher - February 14, 2017

The majority of cases in the world's largest outbreak of Ebola were caused by a tiny handful of patients, research suggests.

The analysis, published in Proceedings of the National Academy of Sciences, shows nearly two thirds of cases (61%) were caused by 3% of infected people.

The young and old were more likely to have been "super-spreaders".



CLICK HERE - Disease “superspreaders” were driving cause of 2014 Ebola epidemic

CLICK HERE - Superspreaders Drove Ebola Epidemic, Study Finds




General Topic Tags: 
Problem, Solution, SitRep, or ?: 

First Ebola-Related Death from Breast Milk Transmission Reported in Guinea

Sissoko D, et al. Clin Infect Dis. 2016;doi:10.1093/cid/ciw79.

CLICK HERE - STUDY -  Ebola virus persistence in breast milk after no reported illness: a likely source of virus transmission from mother to child - January 10, 2017

Genomic analysis confirmed that the 2015 death of a 9-month-old Guinean infant from Ebola virus was the result of transmission through the breast milk of her asymptomatic mother, according to a recent case study.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Ebola RNA Found Hiding in Healthcare Worker’s Lungs



CLICK HERE - STUDY - Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient

A case study reports evidence of viral replication lingering in the respiratory tract of an infected person, even after their blood was Ebola free. - by Bob Grant - January 5, 2017

Ebola virus may linger and continue to replicate in the lungs of patients recovering from infection, even after viral RNA is no longer detectable in their bloodstreams, according to a case study published today (January 5) in PLOS Pathogens. . . .

 . . . Ippolito and his colleagues monitored the Ebola-infected patient, who was moved from West Africa to a hospital in Italy in 2015, over the course of their infection. They found viral RNA and other markers of viral replication in the patient’s lungs five days after such markers were no longer detectable in the blood.


General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Final Trial Results Confirm Ebola Vaccine Provides High Protection Against Disease


23 DECEMBER 2016 | GENEVA - An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.

The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11 841 people in Guinea during 2015. Among the 5837 people who received the vaccine, no Ebola cases were recorded 10 days or more after vaccination. In comparison, there were 23 cases 10 days or more after vaccination among those who did not receive the vaccine.

The trial was led by WHO, together with Guinea’s Ministry of Health and other international partners.


CLICK HERE - The Lancet - Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Ebola Cluster Traced to Sexual Transmission 15 Months After Man's Illness - September 2, 2016

A cluster of Ebola cases in Guinea earlier this year has been traced to sexual transmission from a man who had recovered from the disease close to 15 months earlier, marking the longest known period of sexual transmissibility after recovery from the disease.

"Evidence for sexual transmission of the persisting EBOV in February 2016, about 470 days after onset of symptoms in the survivor, is compelling," says the report by an international team of researchers, published yesterday in Clinical Infectious Diseases.

The cluster involved 3 probable and 7 confirmed cases in Guinea, with 8 deaths, in February, March, and April of this year, the report says.


CLICK HERE - CID - Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days


General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Ebola Virus Persists in Semen Far Longer Than Thought, Study Finds - by Helen Branswell - August 30, 2016

CLICK HERE - The Lancet Global Health - Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data

The Ebola virus can hide itself in the testicles of men who’ve survived the disease for far longer than had been previously thought, a new study suggests.

In fact, the research reports on a man who was still emitting fragments of Ebola viruses in his semen 565 days after he became ill — or 18 months. . . .

. . . suggesting it may be due to age-related changes in the immune system.

. . . The work, published Tuesday in the journal Lancet Global Health, was done by scientists from the Liberian Ministry of Health, the Centers for Disease Control and Prevention, and the World Health Organization. . . .



General Topic Tags: 
Problem, Solution, SitRep, or ?: 

How Likely Are You To Deal With A Zika Outbreak? Check This Map - August 15th 2016 - Anna Almendrala

Now that Zika virus is spreading locally in Florida, U.S. residents, and especially pregnant women, are growing alarmed at the risk that they may face in their own communities. 

A new map estimating the risk of local Zika spread around the globe shows a relatively small likelihood that most of North America and Northern Asia will be affected. By contrast, all the variables are in place for local spread in most of Africa, South and Southeast Asia. 


Country / Region Tags: 
Problem, Solution, SitRep, or ?: 


Subscribe to Contagion
howdy folks